Jackson Creek Investment Advisors LLC Halozyme Therapeutics, Inc. Transaction History

Jackson Creek Investment Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$37.35 - $48.3 $703,935 - $910,310	18,847 New	18,847 $922,000
Q1 2022 May 03, 2022	SELL	$31.97 - $41.06 $803,470 - $1.03 Million	-25,132 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$31.82 - $40.75 $55,844 - $71,516	-1,755 Reduced 6.53%	25,132 $1.01 Million
Q3 2021 Nov 02, 2021	BUY	$38.47 - $46.42 $1.03 Million - $1.25 Million	26,887 New	26,887 $1.09 Million
Q2 2021 Aug 03, 2021	SELL	$38.84 - $51.31 $1.07 Million - $1.42 Million	-27,633 Closed	0 $0
Q1 2021 May 27, 2021	SELL	$39.51 - $51.45 $32,437 - $42,240	-821 Reduced 2.89%	27,633 $1.15 Million
Q4 2020 Feb 03, 2021	SELL	$25.81 - $43.62 $309,023 - $522,262	-11,973 Reduced 29.62%	28,454 $1.22 Million
Q3 2020 Nov 09, 2020	BUY	$25.74 - $29.63 $1.04 Million - $1.2 Million	40,427 New	40,427 $1.06 Million

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.